Polymerase chain reaction versus enzyme-linked immunosorbent assay in detection of Chlamydia trachomatis infection among gynaecological patients in southwestern Nigeria by Ajani, T.A. et al.
76 
 
ORIGINAL ARTICLE     
AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY   MAY 2018   ISBN 1595-689X VOL19 No.2                            
AJCEM/1811                                                                                                                       http://www.ajol.info/journals/ajcem                       
COPYRIGHT 2018  https://dx.doi.org/10.4314/ajcem.v19i2.1                                                                                                                                                                                                   
AFR. J. CLN. EXPER. MICROBIOL. 19 (2): 76-83 
POLYMERASE CHAIN REACTION VERSUS ENZYME-LINKED IMMUNOSORBENT ASSAY IN DETECTION 
OF CHLAMYDIA TRACHOMATIS INFECTION AMONG GYNAECOLOGICAL PATIENTS IN SOUTH-
WESTERN NIGERIA  
 
Ajani1 T. A.; Anaedobe2 C.G.; Oluwasola3 T.A.; Ajani4 M. A. ; Fayemiwo1 S.A. & Bakare1 R.A 
 
1 Department of Medical Microbiology and Parasitology, University College Hospital, Ibadan, Oyo State, Nigeria; 
 2 Department of Medical Microbiology and Parasitology, University of Abuja, FCT, Nigeria; 
 3Department of Obstetrics and Gynaecology, University College Hospital, Ibadan, Oyo State, Nigeria; 
 4 Department of Histopathology, Babcock University, Ilishan-Remo, Ogun State 
 
Correspondence: Dr. Anaedobe Chinenye Gloria, Department of Medical Microbiology and Parasitology, University of Abuja, 




Background: Chlamydia trachomatis (C. trachomatis), is the most common bacterial Sexually Transmitted Infection, a major 
cause of Pelvic Inflammatory Disease and female infertility. Since C. trachomatis infections are frequently asymptomatic with 
higher prevalence in developing countries, highly sensitive and affordable methods are desirable for routine screening and 
diagnosis. This study aimed to evaluate the performance of C. trachomatis-specific IgG antibody by ELISA as a screening tool 
for C. trachomatis infection, by comparing the performance of ELISA with the gold standard Polymerase Chain Reaction (PCR).  
Method: In this cross sectional study, we enrolled 150 women attending infertility clinic at Ibadan between January and 
November, 2015. ELISA for detection of IgG antibodies specific to C. trachomatis major outer membrane protein (MOMP) was 
performed on the blood samples using third generation indirect Enzyme Linked Immunosorbent Assay (ELISA) and 
endocervical samples were analyzed for presence of C. trachomatis nucleic acid using PCR. Socio-demographic bio-data and 
gynaecological history were obtained with questionnaire; data was analyzed using SPSS version 20.0.  
Results: Overall, 58 (38.7%) were positive for C. trachomatis specific IgG antibody by ELISA and 11 (7.3%) for C. trachomatis 
nucleic acid by PCR. Using PCR as the gold standard, ELISA had a sensitivity of 81.8% specificity of 64.8%, positive predictive 
value of 15.5% negative predictive value of 97.8% and accuracy of 66%. 
Conclusion: The high sensitivity of the ELISA indicates that over 80% of patients identified as being positive in the screened 
population are truly infected. Also, the negative predictive value approaches 100% amongst those screened out as being 
negative. Thus its use as a screening tool for C. trachomatis infection is warranted particularly in developing countries where 
cheaper and easier to use alternatives to PCR are in dire need. 
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Background: Chlamydia trachomatis (C. trachomatis), est la plus courante infection bactérienne transmise sexuellement, une 
cause majeure de maladie inflammatoire pelvienne et de l'infertilité féminine. Depuis les infections à C. trachomatis sont 
fréquemment asymptomatique avec une prévalence plus importante dans les pays en développement, particulièrement sensible 
et méthodes abordables sont souhaitables pour le dépistage de routine et le diagnostic. Cette étude visait à évaluer la 
performance de C. trachomatis anticorps IgG spécifiques par ELISA comme un outil de dépistage pour l'infection à C. 
trachomatis, en comparant le rendement d'ELISA à l'étalon de la réaction en chaîne par polymérase (PCR). 
Méthode: Dans cette étude transversale, nous avons inscrit 150 femmes fréquentant une clinique d'infertilité à Ibadan, entre 
janvier et novembre 2015. ELISA pour la détection des anticorps IgG spécifiques à C. trachomatis grande protéine de la 
membrane externe (MOMP) a été effectuée sur les échantillons de sang à l'aide indirecte de troisième génération dosage 
immunoenzymatique (ELISA) et endocervical les échantillons ont été analysés pour la présence de C. trachomatis par PCR de 
l'acide nucléique. Bio-socio-démographiques et des données de l'histoire gynécologique ont été obtenus avec questionnaire ; les 
données ont été analysées à l'aide de SPSS version 20.0. 
Résultats: au total, 58 (38,7  %) étaient positif pour C. trachomatis anticorps IgG spécifiques par ELISA et 11 (7,3  %) pour C. 
trachomatis par PCR de l'acide nucléique. Par PCR comme le gold standard, ELISA avait une sensibilité de 81,8  % de spécificité 
de 64,8  %, valeur prédictive positive de 15,5  % valeur prédictive négative de 97,8  % et la précision de 66 %. 
Conclusion: La grande sensibilité de l'ELISA indique que plus de 80 % des patients identifiés comme étant positifs dans la 
population de dépistage sont vraiment infecté. En outre, la valeur prédictive négative de 100 % des approches parmi ceux 
éliminés comme étant négatif. Ainsi, son utilisation comme outil de dépistage pour l'infection à C. trachomatis est justifiée en 
particulier dans les pays où moins cher et plus facile d'utiliser des alternatives à PCR ont grandement besoin. 
Mots clés: C. trachomatis, infertilité, réaction de polymérisation en chaîne, ELISA, les infections sexuellement transmissibles. 
 
INTRODUCTION 
C. trachomatis (serotypes D–K) are obligatory 
intracellular gram-negative bacteria; it is one of the 
most common bacterial causes of Sexually 
Transmitted Infections (STIs) and a major cause of 
Pelvic Inflammatory Disease (PID) in women [1]. 
Genital C. trachomatis infections are often 
asymptomatic in up to 80% of women causing a wide 
spectrum of diseases which can be complicated by 
tubal factor infertility, ectopic pregnancy and adverse 
pregnancy outcomes [2]. 
In 2010, sexually transmitted Chlamydia infection 
reportedly affected about 215 million people globally 
[2]. World Health Organisation estimates that 92 
million new cases of genital C. trachomatis infection 
occur each year globally and more than two-thirds of 
these cases occur in resource-poor countries where 
diagnostic and treatment facilities are very limited [3-
5]. In most developing countries, tubal factor 
infertility often results from pelvic infections and is 
frequently caused by sexually transmitted C. 
trachomatis infection [3]. In Nigeria, infertility is a 
major public health concern, with a prevalence of 20% 
to 40% compared with global prevalence of 15% [6]. 
Despite this high prevalence, C. trachomatis infection 
is not routinely screened for, even among patients 
being managed for infertility.  
Diagnostic techniques for C. trachomatis infection 
include cell culture, cytology, conventional serology,  
 
 
direct florescent antibody (DFA), enzyme-linked 
immunosorbent assay (ELISA), DNA hybridization 
techniques and polymerase chain reaction (PCR). [7]. 
Cell culture method, previously regarded as gold 
standard is expensive, technically demanding and 
difficult to standardize [7]. The conventional 
serological assays are not without limitations as it has 
been reported that serum antibody is not always 
consistent with active infection especially in regions 
of high prevalence of C. trachomatis [8]. The presence 
of antibodies cannot differentiate an acute, chronic or 
a resolved C. trachomatis infection and cross-reactive 
antibodies are sometimes produced in response to 
lipopolysaccharides of other Chlamydia species such 
as C. pneumoniae and Gram-negative bacterial 
lipopolysacchradies leading to high number of false 
positive results [9]. To address this limitation, direct 
florescent antibody (DFA), ELISA for the detection of 
IgG antibody specific for C. trachomatis infection and 
chlamydial antigens in clinical specimens have been 
made available. The DFA uses monoclonal antibodies 
directed against specie specific antigens on 
chlamydial MOMP while the ELISA detects IgG 
antibodies specific to C. trachomatis MOMP or 
lipopolysaccharide [10] as well as specific antigens 
extracted from chlamydial elementary bodies [9].  
Both DFA and ELISA are reported to have a higher 
sensitivity and specificity with lower false positive 
results [9, 10]. 
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Nucleic acid amplification tests, (NAAT), such as  
PCR and ligase chain reaction are more sensitive and 
specific than conventional immunoassays as they 
target unique nucleic acid (DNA or RNA) of the 
chlamydial organism [11, 12 13] and do not require 
viable organisms to detect infection [14]. PCR  is 
considered to be more reliable for diagnosis of 
asymptomatic pelvic infection caused by C. 
trachomatis  as these infections are often associated 
with low copy numbers and are often missed by less 
accurate microbiology diagnostic techniques [15].  
While detection by PCR has better performance for 
the detection of C. trachomatis and now considered as 
a gold standard, they require special laboratories, 
equipment, and expertise which are apparently 
impracticable in most developing countries [7]. 
Hence, there is need for more affordable and easier to 
perform diagnostic assays with fast throughput of 
high number of specimen, such as C. trachomatis-
specific IgG antibody detection assay. This assay has 
better performance than conventional serodiagnostic 
assays like the non- specific antibody detection 
immunoassays [9,10]. However, this specie- specific 
antibody assay can assist but cannot replace antigen 
detection immunoassays, molecular tests or isolation 
of the organism by the culture technique [7, 11-13].  
Chlamydia screening programs in women of 
reproductive age facilitates prompt diagnosis and 
therapeutic intervention, thus reducing the morbidity 
from long term complications and the prevalence of 
the disease by controlling its transmission and future 
exposures.  
In Nigeria, very few studies on genital Chlamydia 
infection and infertility have been performed using C. 
trachomatis-specific antibody detection immunoassay 
which has no cross-reactivity with other chlamydial 
species. Hence the performance of the C. trachomatis- 
specific antibody detection assays as a screening tool 
has not been ascertained. The objective of the study 
was to evaluate the performance of C. trachomatis-
specific IgG antibody ELISA technique as a screening 
tool for C. trachomatis infection among infertile 
women, by comparing the performance of the ELISA 
with the gold standard Polymerase Chain Reaction 
(PCR).  
 
MATERIALS AND METHODS 
Study Design 
This was a cross-sectional study, in which consenting 
women, attending infertility clinic at the University 
College Hospital in Ibadan, Nigeria were recruited 
and their blood and endocervical specimens taken for 
analyses. Semi structured questionnaires which had 
been pretested and validated, were used to obtain 
socio-demographic characteristics and gynaecological 
history from the study participants. 
Study Population: Sample size was calculated to give 
a 95% confidence level, a margin of error of 10%, 
using a prevalence of 9.8% reported in a previous 
survey on the prevalence of C. trachomatis infection 
among attendees of a fertility clinic in Abeokuta, 
Ogun state, Nigeria [16]. A total of a hundred and 
fifty (150) consenting women with ages ranging 
between 20 and 40 years were recruited between 
January and November 2015. A written informed 
consent was obtained after careful explanation, in a 
clear language, of the concept of the study to each 
participant before their inclusion in the study. Ethical 
clearance was sought and obtained from the Joint 
Ethical committee of the University of Ibadan and 
University College Hospital Ibadan before the 
commencement of the study.  
Ethical Approval: The study protocol was approved 
by the Institutional Review Board of the University of 
Ibadan, and the University College Hospital both in 
Oyo State, Nigeria. 
Consent: Written informed consent was voluntarily 
signed by all the study participants. 
Specimen collection and handling: Venous blood 
and endocervical swab were taken from each woman 
recruited into the study. About 3mls of venous blood 
was collected aseptically by venipuncture into EDTA 
bottles. The plasma was separated by centrifugation 
at room temperature at 3000 rpm and stored in 
aliquots in the freezer at -200C. This was done on 
every visit to the Gynaecology clinic.  
Collection of the endocervical swab was done under 
aseptic condition for each recruited woman. The 
patients were placed in lithotomy position, and then 
sterile speculum was inserted into the vagina to 
expose the cervical os. A sterile copan eNat cervical 
swabs were introduced into the endocervix to collect 
endocervical specimen. Care was taken not to touch 
the walls of the vagina and the speculum. The swabs 
were subsequently put inside eNat preservation 
medium and stored at -20 oC in the freezer until 
processing. 
Laboratory Investigations: All samples were 
analyzed, using an indirect third generation ELISA 
for the detection of C. trachomatis-specific IgG 
antibody in human plasma using microplates coated 
with immunodominant species specific polypeptide 
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derived from C. trachomatis MOMP (DIA-PRO by 
Diagnostic Bioprobes Milano Italy). Protocol for the 
measurement was done according to the 
manufacturer’s instruction and reading was done at 
optical density (O.D.) of 450 nm with an Enzyme –
linked Immunoassay (EIA) plate reader. The tests ran 
were validated and results were interpreted 
according to the manufacturer’s instruction.  
C. trachomatis nucleic acid was extracted from the 
endocervical specimen of all 150 study participants, 
using Jena Bioscience Bacteria DNA preparation kit. 
A thermocycler was used to run the polymerase chain 
reaction for the amplification of a 240 base pair 
sequence of the cryptic plasmid DNA (Biomers 
Germany), the amplified product was subjected to 
electrophoresis using 1.5% agarose gel and visualized 
under an ultraviolet (UV) transilluminator. All tests 
were carried out according to the manufacturer's 
instructions as outlined in the package inserts.  
Data Analysis: Data collected were subjected to 
descriptive and inferential statistical analysis using 
SPSS version 20. (SPSS Inc. Illinois, USA). The Mean, 
standard deviation and test of comparison using 
student's t-test were calculated for continuous 
variables, while categorical variables were 
summarized as proportions, and further analyzed 
using Chi square and Fisher's exact test to assess 
association between the variables. Test of association 
using logistic regression was done to describe the 
relationship between the predictor variables. A P 
value < 0.05 was considered statistically significant. 
RESULTS 
Socio-demographic characteristics of the 
participants: The 150 participants aged between 20 
years to 40 years, had a mean age of 34.1± 5.6 years, 
with most of the women within the 30-39 year age 
range (64%). Majority of the respondents 89/150 
(59.3%) had secondary infertility while the remaining 
61/150 (40.7%) had primary infertility. The socio-
demographic characteristics are as illustrated in Table 
1. 
Prevalence of C. trachomatis infection: Of the 150 
infertile women enrolled in the study, C. trachomatis 
specific IgG antibody was detected in 58(38.7%) using 
ELISA, while the rate of C. trachomatis infection 
confirmed by PCR was 11(7.3%). Of the 58 positive 
results by ELISA, only 9 were true positive after 
confirmation by PCR, while the rest 49 were false 
positive. ELISA was able to detect 9 out of the 11 
women confirmed with C. trachomatis infection. 
 
TABLE 1: SOCIO-DEMOGRAPHIC FACTORS AND 




Performance evaluation of ELISA screening result in 
Comparison to PCR:  
After confirmation test with PCR, the performance of 
ELISA screening result was evaluated for:  
True positive (Number of participants that are ELISA 
positive and PCR positive),  
 
Variables Frequency  Percentage  
Age groups (in years) 
 
20 – 29 







































































































































































False negative (Number of participants that are ELISA 
negative and PCR positive) 
True negative (Number of participants that are ELISA 
negative and PCR negative) 
False positive (Number of participants that are ELISA 
positive and PCR negative) 
This is further illustrated in table 2 below 
 





Presence of disease confirmed by 
PCR 
 
Present Absent Total  
Positive 9 (true positive) 49 (false 
positive) 
58 





Total 11 139 150 
 
The results of ELISA in comparison to PCR assay 
were statistically significant in the study population 
(χ2=9.3, P< .01), as illustrated in Table 3. The 
sensitivity and specificity of ELISA were 81.8%, 64.8% 
respectively. While the positive predictive value, 
negative predictive value and accuracy of the assay 
for the detection of C. trachomatis infection were 
15.5%, 97.8%, and 66% respectively.   
DISCUSSION   
Genital C. trachomatis infection is a major public 
health concern with potentials for long term 
complications in women including infertility [2]. Due 
to its predominantly asymptomatic presentation; 
mandatory screening of women attending infertility 
clinics is warranted. Also, early detection and prompt 
treatment are critical intervention strategies to curb 
the risk of transmission to sexual partners, prevent 
development of reproductive sequelae and reduce 
disease burden. In regions where it is impracticable to 
set up molecular laboratories for the detection of C. 
trachomatis, there is need for affordable, easier to 
perform and reliable screening tools to ensure early 
detection and management of infected patients. The 
prevalence of asymptomatic genital chlamydial 
infection among the study population using ELISA 
specific for C. trachomatis IgG antibody was 38.7%. 
Confirmation by PCR assay revealed 7.3% of the 150 
women enrolled in this study had C. trachomatis 
nucleic acid in their endocervical specimen.   
This finding on ELISA is comparable with the results 
of other studies; 32.1% reported among infertile 
women in Lagos, 32.4% in Benin and 31% in Zaria, 
Nigeria [11, 17, 18]. However, a lower rate was 
reported from Ibadan by Moharson-Bello et al [19] 
who researched largely among uneducated study 
population who were likely to have lower socio- 
economic status and decreased likelihood of 
presenting to hospitals for health-related problems. 
The disparity may also be due to the difference in the 
principle of action of the screening assay used; C. 
trachomatis specific IgG antibodies with no cross 
reaction with C. pneumonia was used in our study. 
Israel et al reported Chlamydia IgG antibodies in 74% 
of symptomatic women with history of recurrent or 
chronic infection in Port-Harcourt, Nigeria [20].  The 
difference in the prevalence rate can be attributed to 
the type of assay used. C. trachomatis specific IgG 
antibody detection by ELISA is more sensitive and 
specific than the regular IgG antibody detection 
assays and has fewer false positive results.  This may 
also be a reflection of the absence of routine screening 
and treatment for C. trachomatis infections in this 
population. 
TABLE 3: COMPARISON OF THE PREVALENCE OF CHLAMYDIA TRACHOMATIS INFECTION IN RESPONDENTS USING 
PCR AND ELISA (N = 150) 
Variables  PCR  Df X2 p-value 
Positive/(%) Negative/(%) Total /(%)    
ELISA       
Positive 9 (81.8%) 49 (35.3%) 58 (38.7%) 1 9.3 0.002 
Negative 2 (18.2%) 90 (64.7%) 92 (61.3%)    
Total 11 (100%) 139 (100%) 150 (100%)    
 
Sensitivity = True positive/ (True positive+ False negative); Specificity= True negative/ (True negative+ False positive)                     
Positive predictive value =True positive/(True positive + False positive); Negative predictive value = True negative/ (True 
negative+ False negative); Accuracy = True positive + True negative/(total screened patients); The sensitivity of ELISA = 9\11 x 
100 = 81.81%; The specificity of ELISA =90\139 x 100 = 64.75%; The Positive predictive value = 9/58 x 100= 15.52%; nThe negative 
predictive value =90/92 x 100= 97.83%; Accuracy of ELISA = 9+90/ 150 x 100 = 66%; P value =0.002 (significant) 
By principle of action, the specie specific antibody 
detection immunoassay used in our study is different 
from other regular antibody detection immunoassays. 
It uses highly specific and immunogenic antigen 
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derived from C. trachomatis MOMP to detect 
chlamydial antibodies and has no cross reactivity 
with C. pneumonia antibodies. A major drawback of 
the regular IgG antibody detection assays is that it 
does not distinguish between species. Cross-reactive 
antibodies bound to lipopolysaccharides of other 
Chlamydia species including C. pneumoniae and Gram-
negative bacterial lipopolysaccharides makes such 
assay less sensitive and specific as a screening tool for 
C. trachomatis infection. Invariably; there will be high 
false-positive test results if used in regions of high 
prevalence of Chlamydial infection [9].  
In other Africa regions, prevalence rates of between 
36% and 39.3% have been reported among women 
with unexplained infertility [4,21] although a lower 
prevalence of 18.5% was reported among 
symptomatic participants in Rwanda [22]. It was 
noted by the authors that vigorous treatment-seeking 
behaviour was common among women in infertile 
relationships when facing genital symptoms in that 
environment and this perhaps had resulted in early 
treatment before aetiologic diagnosis was achieved.  
Findings from our study and in the literature, suggest 
a high prevalence of asymptomatic genital C. 
trachomatis infection among infertile women in most 
parts of Africa [23, 24]. The reasons for this might be 
attributed to the poor screening protocol for C. 
trachomatis infection among women of reproductive 
age, the near absent diagnostic and treatment 
facilities, poor health seeking behaviour of these 
women and asymptomatic nature of the infection. In 
order to effectively identify infected women, reliable, 
cheap and easy to use screening assays like the C. 
trachomatis specific IgG antibody detection by ELISA 
may be utilized. 
In other parts of the world, lower prevalence rates 
have been reported; 9% in Iran, [25] 25% in Baghdad, 
[26] 21.1%, 15.20 %, and 9.84% in Netherlands, 
Romania and Saudi Arabia respectively [27, 28, 30]. 
Improved medical facilities for early detection and 
prompt treatment of C. trachomatis infection may 
account for these low prevalence rates.  
The prevalence of C. trachomatis infection varies with 
different study population, specimen type, presence 
of clinical symptoms, previous or chronic infection, 
type and sensitivity of the microbiology diagnostic 
methods used and the laboratory expertise.  
 
In the index study, using PCR as gold standard, 
ELISA has a sensitivity of 81%, specificity of 65%, 
positive and negative predictive values of 16% and 
98% in that order, all approximated. Our findings of 
high sensitivity, moderate specificity, [29] low 
positive predictive value and high negative predictive 
value [22] were in tandem from similar studies in 
India and Rwanda [22, 29]. In Iran, Batool et al 
reported a low sensitivity and high specificity of the 
ELISA but a low positive predictive value and high 
negative predictive value similar to that observed in 
our study [25]. The participants in the Iranian study  
were symptomatic with possible active infection and 
the regular IgG antibody detection immunoassay 
used is said to have low sensitivity in people with 
active infection and does not distinguish between 
species [9, 10].  
Molecular assay for detection of chlamydial DNA are 
the preferred investigations for diagnosis of C. 
trachomatis infection in all specimen types. However, 
this is not practicable in resource poor regions and 
comparable alternatives are of upmost importance. 
The high sensitivity and moderate specificity of the C. 
trachomatis specific IgG antibody detection by ELISA 
suggests it can be a good screening tool particularly in 
regions of relatively high prevalence of C. trachomatis 
infection albeit the tendency to give false positive 
result. In other words, the high sensitivity of the 
ELISA indicates that over 80% of patients identified as 
being positive in the screened population are truly 
infected. Also, the negative predictive value 
approaches 100% amongst those screened out as 
being negative, indicating that the women with 
negative results were unlikely to be infected. The low 
positive predictive value indicates that ELISA is not 
without limitations, therefore positive test results 
should be confirmed by PCR especially amidst the 
asymptomatic patient. At this point, the screening 
tool has largely reduced the number of patients for 
confirmatory test thus saving cost.  
ELISA for detection of chlamydial antibodies in 
clinical specimens using C. trachomatis MOMP has 
been studied extensively as a screening tool and has 
been reported to have good performance when 
compared with the gold standard [9,26-27,29-32]. 
Thus, the affordability, easy application and high 
throughput of the immunoassay, makes it a practical 
screening tool in regions of high C trachomatis 
prevalence and a good substitution for the more 
sensitive and specific PCR especially low-income 
countries.  
A limitation to this study is the different specimen 
type used; plasma for the ELISA and endocervical 
specimen for the PCR. To allow a scientifically valid 
comparison and evaluation of performance of ELISA 
using PCR results as gold standards, both tests should 
be performed on the same single specimen and the 
study should include a substantial number of true-
positive results. It is important to point out that the 
diagnosis of acute C. trachomatis infection is based on 
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direct detection of the organism, in this case, 
serodiagnosis are of limited value. 
Conclusion:  
The high prevalence of asymptomatic C. trachomatis 
infection among infertile women documented in this 
study underscores the need for routine screening for 
chlamydial infection among them. C. trachomatis 
specific IgG antibody detection by ELISA gave 
comparable results in more than 80% of true positive 
samples detected by PCR. This suggests that it is a 
practical and cheaper alternative to the molecular 
tests for routine screening and diagnosis especially in 
resource poor countries. 
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